Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Novavax Inc
(NQ:
NVAX
)
4.090
+0.140 (+3.54%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Novavax Inc
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
53
54
Next >
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
March 01, 2023
It's time to start the day with another breakdown of the biggest pre-market stock movers traders need to know about on Wednesday!
Via
InvestorPlace
Resilient Stocks Look To Break Free As Nasdaq, S&P 500 Futures Climb: Brace For More Volatility, Sideways Movement Near Term, Says Analyst
March 01, 2023
Stocks could attempt to return to their winning ways on Wednesday following the lackluster performance in the previous session. Mixed earnings news flow could, however, act as a dampener. Cues From...
Via
Benzinga
Novavax, AMC Entertainment And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
March 01, 2023
U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
Novavax Stock Down On Concern Over Whether The Company Can Continue
February 28, 2023
Novavax warns that it may not be able to continue as a company.
Via
Talk Markets
Here's The Good News For Novavax Ahead Of Its Fourth-Quarter Report
February 28, 2023
Novavax is expected to report strong sales growth. But 2023 guidance will be key.
Via
Investor's Business Daily
Earnings Preview: Novavax
February 27, 2023
Via
Benzinga
Tesla, Apple, AMC, Novavax, Rivian: Why These 5 Stocks Are Drawing Investors' Attention Today
February 28, 2023
Via
Benzinga
Rivian's Slamming on the Brakes, but This Vaccine Stock Is Falling Harder
February 28, 2023
A couple of high-profile companies posted big declines in after-hours trading on Tuesday.
Via
The Motley Fool
12 Health Care Stocks Moving In Tuesday's After-Market Session
February 28, 2023
Via
Benzinga
After-Hours Alert: Why Novavax Stock Is Plunging
February 28, 2023
Novavax Inc (NASDAQ: NVAX) shares are tanking in Tuesday's after-hours session after the company reported weak fourth-quarter re
Via
Benzinga
2 Stocks to Sell or Remove From Your Watchlist in 2023
February 28, 2023
Both stocks soared during the coronavirus vaccine race, but their time has passed.
Via
The Motley Fool
Why Novavax Stock Wilted on Wednesday
February 22, 2023
It doesn't seem like investors are looking forward to the company's fourth-quarter and full-year 2022 earnings release.
Via
The Motley Fool
More Likely to 5x First: Novavax vs. Ocugen
February 16, 2023
They skyrocketed before. It could happen again.
Via
The Motley Fool
Coronavirus Vaccine Market To Surpass $95 Billion By 2028
February 28, 2023
EQNX::TICKER_START (NASDAQ:SBFM),(NASDAQ:MRNA),(NASDAQ:NVAX),(NASDAQ:VIR),(NASDAQ:INO) EQNX::TICKER_END
Via
FinancialNewsMedia
Exposures
COVID-19
Nasdaq, S&P 500 Futures Flatline Ahead Of Housing, Consumer Data: Analyst Pins Hopes On Dollar, Fed Rates To Keep Flickering Rally Hopes Alive
February 28, 2023
Trading in the U.S. index futures suggests stocks may start Tuesday’s session slightly higher, although the mood could be cautious ahead of some key economic data on the housing market, business...
Via
Benzinga
3 Supercharged Growth Stocks Down 89% to 97% That Billionaires Can't Stop Buying
February 23, 2023
Beaten-down growth stocks were popular buys during the fourth quarter for some of the brightest billionaire money managers.
Via
The Motley Fool
Earnings Scheduled For February 28, 2023
February 28, 2023
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report earnings for its fourth quarter.
Via
Benzinga
2 Beaten-Down Stocks That Might Be too Cheap to Ignore
February 22, 2023
There is an argument for hitting the buy button, but it's important to consider the potential risks too.
Via
The Motley Fool
Harmony Biosciences, The No. 3 Biotech, Just Topped Forecasts; But Concerns Persist
February 21, 2023
The company offered neither financial guidance nor plans for a new CEO.
Via
Investor's Business Daily
Is This the Telltale Sign to Sell Novavax Stock?
February 14, 2023
You won't find Novavax's latest bad news trumpeted in a press release.
Via
The Motley Fool
Why Is Monday.com (MNDY) Stock Up 11% Today?
February 13, 2023
Monday.com (MNDY) stock is on the rise Monday after announcing a partnership with Appfire to expand its app marketplace.
Via
InvestorPlace
NVAX Stock Alert: Novavax Will Provide 1.5 Million More Covid-19 Vaccine Doses to U.S.
February 13, 2023
Novavax (NVAX) stock is on the move Monday after extending its Covid-19 vaccine supply agreement with the U.S. government.
Via
InvestorPlace
These Cheap Growth Stocks Could Supercharge Your Portfolio
February 12, 2023
All of these players are cheap today considering their growth potential.
Via
The Motley Fool
Is Novavax Stock a Buy With the New Normal for COVID?
February 10, 2023
The landscape has shifted dramatically in the COVID-19 vaccine market.
Via
The Motley Fool
Better Buy: Novavax or BioNTech Stock?
February 04, 2023
The two companies, known for their vaccines, could see their businesses benefit from a yearly COVID-19 shot.
Via
The Motley Fool
MarketBeat Week in Review – 1/30 - 2/3
February 04, 2023
The markets are trending lower to end the week. It’s hard to figure out the markets after the blockbuster job report, but the MarketBeat team gave it a shot
Via
MarketBeat
Topics
Artificial Intelligence
Earnings
Economy
Exposures
Artificial Intelligence
Financial
Interest Rates
3 Sorry Pharma Stocks to Sell in February Before It’s Too Late
February 01, 2023
These are the pharma stocks to sell, as they represent companies with weak fundamentals and sustained cash burn visibility.
Via
InvestorPlace
Novavax Shares Jumped in January While Others Slipped
February 01, 2023
Updated FDA Covid vaccine policy could've boosted NVAX shares at the end of January, when other pharma stocks slipped, but it may not affect the bottom line.
Via
MarketBeat
Exposures
COVID-19
Product Safety
1 Reason to Buy Novavax in 2023 and 2 Reasons to Sell
February 01, 2023
Novavax shares sank 93% last year.
Via
The Motley Fool
$1,000 Invested In 4 Of The 5 Vaccine Developers Back When WHO Declared COVID-19 An Emergency Yielded Returns
January 30, 2023
The COVID-19 pandemic emerged in 2019 in China and spread to the rest of the globe in early 2020. Since then, the virus has caused more than 6.8 million deaths.
Via
Benzinga
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
53
54
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.